Lab
Oklahoma State Department of Health
Oklahoma State Department of Health was paid $5.16M by Medicaid between Jan 2018 and Dec 2024, across 13 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 42% of everything it billed.
33Billing provider infoOKLAHOMA STATE DEPARTMENT OF HEALTH
OKLAHOMA CITY, OK 73102
OKLAHOMA CITY, OK 73102
33aNPI1174790513assigned 05/14/2008
33bProvider typeClinical Medical Laboratory
28Total paid$5.16M
24GClaims178,396
24DCodes billed13
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Oklahoma
Rank by total paid#7 of 46
Median peer was paid$248K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,307 | $780K | |
| 2019 | 19,385 | $549K | |
| 2020 | 27,026 | $692K | |
| 2021 | 22,949 | $661K | |
| 2022 | 35,373 | $931K | |
| 2023 | 36,731 | $1.12M | |
| 2024incomplete | 12,625 | $429K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 42% | 60,604 | 60,203 | $2.15M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 42% | 60,495 | 60,098 | $2.14M |
| 86780 | 4.6% | 21,946 | 21,722 | $239K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.2% | 9,785 | 9,704 | $217K |
| 86703 | 2.3% | 13,254 | 13,232 | $117K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.0% | 3,235 | 3,231 | $103K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.9% | 2,985 | 2,897 | $96K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,490 | 1,463 | $76K |
| 86592 | <1% | 3,876 | 3,787 | $16K | |
| 86701 | <1% | 688 | 683 | $6K | |
| 87046 | <1% | 13 | 13 | $147.56 | |
| 87045 | <1% | 13 | 13 | $112.84 |
1 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 12 | $94.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAI, GITANJALI (CHIEF MEDICAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| State of Oklahoma | Oklahoma City, OK | $6.91M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.